| 1 |
34022417 | In vitro activity of ceftaroline and comparators against bacterial isolates collected globally from patients with skin infections. | 2021 Sep |
1 |
| 2 |
31408445 | Spreading of extended-spectrum β-lactamase-producing Escherichia coli ST131 and Klebsiella pneumoniae ST11 in patients with pneumonia: a molecular epidemiological study. | 2019 Aug 20 |
1 |
| 3 |
31505647 | Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016. | 2019 Aug 1 |
1 |
| 4 |
32040455 | In-vitro activity of tigecycline and comparator agents against common pathogens: Indian experience. | 2019 Mar 31 |
1 |
| 5 |
26513341 | Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options. | 2016 May |
1 |
| 6 |
27256586 | Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. | 2016 Jul |
1 |
| 7 |
24529941 | Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012). | 2014 Apr |
1 |
| 8 |
23114764 | Tigecycline displays in vivo bactericidal activity against extended-spectrum-β-lactamase-producing Enterobacteriaceae after 72-hour exposure period. | 2013 Jan |
3 |
| 9 |
24421836 | Determination of susceptibility to fosfomycin and tigecycline of Enterobacteriaceae, particularly Escherichia coli isolates, producing extended-spectrum β-lactamases from multiple regional Canadian hospitals. | 2013 Fall |
2 |
| 10 |
22155819 | Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010. | 2012 Mar |
3 |
| 11 |
22203598 | Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010. | 2012 Mar |
2 |
| 12 |
22832033 | In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany. | 2012 |
1 |
| 13 |
23198452 | A reflection on bacterial resistance to antimicrobial agents at a major tertiary care center in Lebanon over a decade. | 2012 Jul-Sep |
1 |
| 14 |
23214282 | ESBL-producing Escherichia coli isolated from children with acute diarrhea - antimicrobial susceptibility, adherence patterns and phylogenetic background. | 2012 Mar-Apr |
1 |
| 15 |
22196060 | In vitro activities of nine current antibiotics against culprit bacteria in nosocomial infections in an institution in Northern Taiwan. | 2011 Nov-Dec |
1 |
| 16 |
20818104 | Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. | 2010 Sep 3 |
2 |
| 17 |
18802728 | In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital. | 2009 Apr |
2 |
| 18 |
19015360 | Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials. | 2009 Feb |
1 |
| 19 |
19364850 | In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates. | 2009 Jul |
2 |
| 20 |
18154548 | Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. | 2008 Jan |
2 |
| 21 |
18676620 | Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. | 2008 Nov |
4 |
| 22 |
19013351 | Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae. | 2008 Nov |
3 |